abstract |
Novel calcium release-activated calcium (CRAC) channel inhibitors, methods for their preparation, pharmaceutical compositions containing them and methods of treatment using them are disclosed. The present disclosure also relates to methods of treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods of identifying therapeutic agents for the treatment and diagnosis of cancer. |